The high cost of radon remediation in the 1980s led to detractors arguing that the issue is a financial boondoggle reminiscent of the swine flu scare of 1976. They further argued that the results of mitigation are inconsistent with lowered cancer risk, especially when indoor radon levels are in the lower range of the actionable exposure level.